These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9776305
1. The inhibitory effect of cinchonine on human platelet aggregation due to blockade of calcium influx. Shah BH, Nawaz Z, Virani SS, Ali IQ, Saeed SA, Gilani AH. Biochem Pharmacol; 1998 Oct 15; 56(8):955-60. PubMed ID: 9776305 [Abstract] [Full Text] [Related]
2. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Shah BH, Nawaz Z, Pertani SA, Roomi A, Mahmood H, Saeed SA, Gilani AH. Biochem Pharmacol; 1999 Oct 01; 58(7):1167-72. PubMed ID: 10484074 [Abstract] [Full Text] [Related]
10. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C, Maiolo A, Tua A, Grignani G. Haematologica; 2000 Aug 01; 85(8):820-5. PubMed ID: 10942928 [Abstract] [Full Text] [Related]
11. Pharmacological profile of G619, a new platelet aggregation inhibitor. Yue TL, Smith EF, Ohlstein EH, Sulpizio A, Slivjak MJ, Rabinovici R, Sellers TS, Lynch KM, Poyser R, Feuerstein G. Thromb Res; 1992 May 15; 66(4):331-47. PubMed ID: 1412200 [Abstract] [Full Text] [Related]
12. Synthesis of intracellular histamine in platelets is associated with activation of protein kinase C, but not with mobilization of Ca2+. Saxena SP, Robertson C, Becker AB, Gerrard JM. Biochem J; 1991 Jan 15; 273(Pt 2)(Pt 2):405-8. PubMed ID: 1899334 [Abstract] [Full Text] [Related]
13. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS, Wharton KA, White BP, Lumley P. Br J Pharmacol; 1991 Feb 15; 102(2):497-505. PubMed ID: 1826620 [Abstract] [Full Text] [Related]
14. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF). Steiner M, Landolfi R, Motola NC, Turcotte JG. Biochem Biophys Res Commun; 1985 Dec 31; 133(3):851-5. PubMed ID: 3936503 [Abstract] [Full Text] [Related]
16. [Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation]. Kakushi H, Shike T, Hayasaki Y, Arita H, Uchida K. Nihon Yakurigaku Zasshi; 1991 Aug 31; 98(2):113-20. PubMed ID: 1916541 [Abstract] [Full Text] [Related]
18. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Johnson GJ, Leis LA, Francis GS. Circulation; 1986 Apr 31; 73(4):847-54. PubMed ID: 3004784 [Abstract] [Full Text] [Related]
19. Antiplatelet effect of butylidenephthalide. Teng CM, Chen WY, Ko WC, Ouyang CH. Biochim Biophys Acta; 1987 Jun 22; 924(3):375-82. PubMed ID: 3109495 [Abstract] [Full Text] [Related]
20. Antiplatelet activity of BRX-018, (6aS,cis)-malonic acid 3-acetoxy-6a9-bis-(2-methoxycarbonyl-acetoxy)-6,6a,7,11b-tetrahydro-indeno[2,1-c]chromen-10-yl ester methylester. Lee GY, Chang TS, Lee KS, Khil LY, Kim D, Chung JH, Kim YC, Lee BH, Moon CH, Moon CK. Thromb Res; 2005 Jun 22; 115(4):309-18. PubMed ID: 15668191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]